The Timing of Direct Oral Anticoagulant Usage Did Not Impact Outcomes Following Hip Arthroplasty for Femoral Neck Fractures
Journal of Bone and Joint Surgery · 2025
DOI: 10.2106/jbjs.24.01293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, 2025. Verfasst von Xiao T Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Femoral Neck Fractures, Hemiarthroplasty, Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Orthopaedic surgeons routinely delay surgical management of femoral neck fractures in patients taking direct oral anticoagulants (DOACs) to decrease perioperative bleeding and associated complications. However, this practice contradicts the principles of hip fracture management, as early surgery is associated with morbidity and mortality benefits. The purpose of this study was to quantify the association of DOAC use and perioperative outcomes in patients who underwent hemiarthroplasty (HA) or total hip arthroplasty (THA) for femoral neck fractures. We hypothesized that early surgical intervention on a patient taking a DOAC medication would not lead to worse perioperative outcomes.
Methods
A retrospective cohort study was conducted on 2,833 patients who underwent primary THA or HA for femoral neck fractures between December 31, 2017, and January 29, 2024, across our hospital system. The patients taking a DOAC were divided into 3 groups based on the time since the last DOAC intake: 1 day, 2 days, and ≥3 days. Propensity matching was performed 1:1, accounting for age, sex, Elixhauser Comorbidity Index, preoperative chronic kidney disease stage, preoperative hemoglobin, body mass index, and hospital type. Subanalyses utilizing linear and conditional logistic regression models were performed to assess differences in outcomes between the groups that had a DOAC withheld and the control groups.
Results
The mean age of all patients was 81 ± 10 years, 1,805 patients (64%) were women, and 207 patients (7%) were taking a DOAC prior to surgery. Despite comparable preoperative and postoperative hemoglobin levels between the groups that had a DOAC withheld and the control groups (all p > 0.05), the patients who had a DOAC withheld for 1 day were more likely to receive a postoperative blood transfusion (23.1% compared with 0%; p = 0.002). This difference in transfusion rate was not observed in other cohorts. There were no differences in medical complications, reoperation, discharge disposition, or mortality between the groups that had a DOAC withheld and the matched controls at any time point.
Conclusions
Delaying surgical management due to DOAC medications may be unnecessary in patients undergoing arthroplasty for femoral neck fractures. Consideration should be given to adjusting transfusion triggers to reduce unwarranted blood transfusions in patients taking a DOAC. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
- Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, Florida.
- Division of Health Care Delivery Research, Mayo Clinic, Jacksonville, Florida.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida.
- Department of Orthopedic Surgery, Mayo Clinic, Phoenix, Arizona.
ORCID-Profile: Xiao T Chen, Bryan D Springer, Shalmali Borkar, Aaron Spaulding, Linjun Yang, Cody C Wyles, Steven B Porter, Benjamin K Wilke
Zitieren
APA
Chen, X. T., Springer, B. D., Borkar, S., Spaulding, A., Yang, L., Wyles, C. C., Porter, S. B., Bingham, J. S., & Wilke, B. K. (2025). The Timing of Direct Oral Anticoagulant Usage Did Not Impact Outcomes Following Hip Arthroplasty for Femoral Neck Fractures. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.24.01293
Vancouver
Chen XT, Springer BD, Borkar S, Spaulding A, Yang L, Wyles CC, et al. The Timing of Direct Oral Anticoagulant Usage Did Not Impact Outcomes Following Hip Arthroplasty for Femoral Neck Fractures. Journal of Bone and Joint Surgery. 2025. doi:10.2106/jbjs.24.01293
BibTeX
@article{Chen2025,
author = {Chen, Xiao T and Springer, Bryan D and Borkar, Shalmali and Spaulding, Aaron and Yang, Linjun and Wyles, Cody C and Porter, Steven B and Bingham, Joshua S and Wilke, Benjamin K},
title = {The Timing of Direct Oral Anticoagulant Usage Did Not Impact Outcomes Following Hip Arthroplasty for Femoral Neck Fractures},
journal = {Journal of Bone and Joint Surgery},
year = {2025},
doi = {10.2106/jbjs.24.01293}
}
EUVIMED